Dynavax Technologies Corp...

NASDAQ: DVAX · Real-Time Price · USD
10.70
0.08 (0.75%)
At close: Aug 15, 2025, 12:10 PM

Dynavax Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
27.31M -6.39M 293.16M 76.71M
Depreciation & Amortization
8.05M 7.28M 6.67M 7.01M
Stock-Based Compensation
52.62M 42.59M 32.91M 21.29M
Other Working Capital
2.35M 12.08M -251.01M 282.38M
Other Non-Cash Items
-5.43M 1.12M -33.38M 1.61M
Deferred Income Tax
n/a -5.24M 61.77M 56.69M
Change in Working Capital
-16.04M 61.21M -298.42M 172.22M
Operating Cash Flow
66.51M 100.56M 62.72M 335.53M
Capital Expenditures
-6.35M -4.1M -7.14M -9.48M
Cash Acquisitions
n/a 1M 1M 1M
Purchase of Investments
-524.06M -636.92M -632.31M -164.93M
Sales Maturities Of Investments
512.38M 486.1M 322.45M 187.63M
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-18.04M -153.93M -316M 14.22M
Debt Repayment
n/a n/a n/a 29.63M
Common Stock Repurchased
-100M n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-2.02M -4.97M 1.43M -2.01M
Financial Cash Flow
-102.02M 1.39M 19.52M 55.78M
Net Cash Flow
-54.4M -51.66M -234.2M 404.1M
Free Cash Flow
60.16M 96.46M 55.58M 326.05M